SCHEMBL29567282

SCHEMBL29567282

CC(C)c1ccccc1-c1cc(S(C)(=O)=O)nc(N)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.46
▸ CA12 O43570 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA9 Q16790 2/20 0.41
▸ HTR1B P28222 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ GPR65 Q8IYL9 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ATR Q13535 1/20 0.39
▸ HSP90AA1 P07900 3/20 0.37
▸ HSP90AB1 P08238 2/20 0.37
▸ ALOX5AP P20292 2/20 0.36
▸ FEN1 P39748 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309820 1.00 DHFR (0.46) DHFRCA12CA1CA2CA9
SCHEMBL29566525 0.77 HSP90AA1 (0.64) DHFRHTR1BHTR2BGPR65HSP90AA1
SCHEMBL3946692 0.77 HSP90AA1 (0.64) DHFRHTR1BHTR2BGPR65HSP90AA1
SCHEMBL29567149 0.75 HSP90AA1 (0.62) DHFRHTR1BHTR2BGPR65HSP90AA1
SCHEMBL29567313 0.74 DHFR (0.45) DHFRCA12CA1CA2CA9
SCHEMBL24309341 0.74 DHFR (0.45) DHFRCA12CA1CA2CA9
SCHEMBL24310645 0.72 DHFR (0.43) DHFRCA12CA1CA2CA9
SCHEMBL24773615 0.71 HSP90AA1 (0.43) DHFRL3MBTL1HSP90AA1LMNAMAPT
SCHEMBL24309759 0.70 HTR1A (0.42) MAPTKMT2AEGFR
SCHEMBL26806646 0.70 TSHR (0.36) MEN1LMNAMAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback